About Citrate synthase, mitochondrial
Citrate synthase, mitochondrial (CS) is a protein
from Homo sapiens identified by UniProt accession
O75390, 466 residues long.
MolForge cross-references it against 0 known binders and
387 disease associations.
Target properties
| Protein name | Citrate synthase, mitochondrial |
| UniProt accession | O75390 |
| Gene | CS |
| Organism | Homo sapiens |
| Length | 466 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (387)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.38
- neuroinflammatory disorder · score 0.25
- body height · score 0.20
- appendicular lean mass · score 0.15
- psoriasis · score 0.15
- vital capacity · score 0.14
- body weight · score 0.10
- deafness · score 0.10
- autosomal recessive nonsyndromic hearing loss 1B · score 0.08
- BMI-adjusted waist circumference · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75390-F1 | alphafold | PREDICTED | 94.03 | — |
Amino-acid sequence (466 residues)
MALLTAAARL LGTKNASCLV LAARHASASS TNLKDILADL IPKEQARIKT FRQQHGKTVV GQITVDMMYG GMRGMKGLVY ETSVLDPDEG IRFRGFSIPE CQKLLPKAKG GEEPLPEGLF WLLVTGHIPT EEQVSWLSKE WAKRAALPSH VVTMLDNFPT NLHPMSQLSA AVTALNSESN FARAYAQGIS RTKYWELIYE DSMDLIAKLP CVAAKIYRNL YREGSGIGAI DSNLDWSHNF TNMLGYTDHQ FTELTRLYLT IHSDHEGGNV SAHTSHLVGS ALSDPYLSFA AAMNGLAGPL HGLANQEVLV WLTQLQKEVG KDVSDEKLRD YIWNTLNSGR VVPGYGHAVL RKTDPRYTCQ REFALKHLPN DPMFKLVAQL YKIVPNVLLE QGKAKNPWPN VDAHSGVLLQ YYGMTEMNYY TVLFGVSRAL GVLAQLIWSR ALGFPLERPK SMSTEGLMKF VDSKSG
Explore Citrate synthase, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets